AXON ENTERPRISE INC 05464C101 05/28/2026 Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 656632 36872 FOR 0 FOR LINEAGE CELL THERAPEUTICS INC 53566P109 06/10/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 49560992 0 FOR 0 FOR MONSTER BEVERAGE CORP NEW 61174X109 05/14/2026 Proposal to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 6146278 1961518 FOR 0 FOR INSIGHT MOLECULAR DIA INC 68235C206 06/11/2026 To approve, on a non-binding advisory basis, the company's named executive officer compensation for the year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES 12238674 446210 FOR 0 FOR STAAR SURGICAL CO 852312305 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES 16123842 0 FOR 0 FOR